Literature DB >> 23883407

System accuracy of blood glucose monitoring systems: impact of use by patients and ambient conditions.

Christina Schmid1, Cornelia Haug, Lutz Heinemann, Guido Freckmann.   

Abstract

For self-monitoring of blood glucose by people with diabetes, the reliability of the measured blood glucose values is a prerequisite in order to ensure correct therapeutic decisions. Requirements for system accuracy are defined by the International Organization for Standardization (ISO) in the standard EN ISO 15197:2003. However, even a system with high analytical quality is not a guarantee for accurate and reliable measurement results. Under routine life conditions, blood glucose measurement results are affected by several factors. First, the act of performing measurements as well as the handling of the system may entail numerous possible error sources, such as traces of glucose-containing products on the fingertips, the use of deteriorated test strips, or the incorrect storage of test strips. Second, ambient and sampling conditions such as high altitude, partial pressure of oxygen, ambient temperature, and the use of alternate test sites can have an influence on measurement results. Therefore, the user-friendliness of a system and the quality of the manufacturer's labeling to reduce the risk of handling errors are also important aspects in ensuring reliable and accurate measurement results. In addition, the analytical performance of systems should be less prone to user errors and ambient conditions. Finally, people with diabetes must be aware of the information and instructions in the manufacturer's labeling and must be able to measure and interpret blood glucose results correctly.

Entities:  

Mesh:

Year:  2013        PMID: 23883407     DOI: 10.1089/dia.2013.0047

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  6 in total

1.  Factory-Calibrated Continuous Glucose Sensors: The Science Behind the Technology.

Authors:  Udo Hoss; Erwin Satrya Budiman
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

Review 2.  Managing diabetes with nanomedicine: challenges and opportunities.

Authors:  Omid Veiseh; Benjamin C Tang; Kathryn A Whitehead; Daniel G Anderson; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-11-28       Impact factor: 84.694

Review 3.  Nanomedicine-Based Strategies for Diabetes: Diagnostics, Monitoring, and Treatment.

Authors:  Luke R Lemmerman; Devleena Das; Natalia Higuita-Castro; Raghavendra G Mirmira; Daniel Gallego-Perez
Journal:  Trends Endocrinol Metab       Date:  2020-03-04       Impact factor: 12.015

Review 4.  Interferences and Limitations in Blood Glucose Self-Testing: An Overview of the Current Knowledge.

Authors:  Michael Erbach; Guido Freckmann; Rolf Hinzmann; Bernhard Kulzer; Ralph Ziegler; Lutz Heinemann; Oliver Schnell
Journal:  J Diabetes Sci Technol       Date:  2016-08-22

Review 5.  Monitoring of Pediatric Type 1 Diabetes.

Authors:  Brynn E Marks; Joseph I Wolfsdorf
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-17       Impact factor: 5.555

6.  Managing diabetes at high altitude: personal experience with support from a Multidisciplinary Physical Activity and Diabetes Clinic.

Authors:  Gary Malcolm; Sian Rilstone; Sivasujan Sivasubramaniyam; Carol Jairam; Stephen Chew; Nick Oliver; Neil E Hill
Journal:  BMJ Open Sport Exerc Med       Date:  2017-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.